These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30303244)

  • 1. Cancer patients' experiences with urgent referrals to cancer patient pathways.
    Sandager M; Jensen H; Lipczak H; Sperling CD; Vedsted P
    Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12927. PubMed ID: 30303244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study.
    Jensen H; Tørring ML; Olesen F; Overgaard J; Vedsted P
    BMC Cancer; 2014 Aug; 14():636. PubMed ID: 25175155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care.
    Jensen H; Tørring ML; Vedsted P
    BMC Cancer; 2017 Sep; 17(1):627. PubMed ID: 28874125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer suspicion, urgent referral and time to diagnosis in Danish general practice: a population-based study.
    Baun ML; Jensen H; Falborg AZ; Heje HN; Petersen LK; Vedsted P
    Fam Pract; 2019 Nov; 36(6):751-757. PubMed ID: 31046091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour stage and implementation of standardised cancer patient pathways: a comparative cohort study.
    Jensen H; Tørring ML; Fenger-Grøn M; Olesen F; Overgaard J; Vedsted P
    Br J Gen Pract; 2016 Jun; 66(647):e434-43. PubMed ID: 27025558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing pancreatic cancer in general practice: a cross-sectional study on associations between suspicion of cancer, urgent referral and time to diagnosis.
    Virgilsen LF; Rasmussen LA; Vedsted P; Jensen H
    Scand J Prim Health Care; 2022 Mar; 40(1):78-86. PubMed ID: 35148665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cancer and repeated urgent referral after negative investigation for cancer.
    Nielsen N; Vedsted P; Jensen H
    Fam Pract; 2018 Sep; 35(5):582-588. PubMed ID: 29420706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a continuing medical education meeting on the use and timing of urgent cancer referrals among general practitioners - a before-after study.
    Toftegaard BS; Bro F; Falborg AZ; Vedsted P
    BMC Fam Pract; 2017 Mar; 18(1):44. PubMed ID: 28327100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of standardised cancer pathways on Danish cancer patients' dissatisfaction with waiting time.
    Dahl TL; Vedsted P; Jensen H
    Dan Med J; 2017 Jan; 64(1):. PubMed ID: 28007051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer suspicion, referral to cancer patient pathway and primary care interval: a survey and register study exploring 10 different types of abdominal cancer.
    Jessen NH; Jensen H; Helsper CW; Falborg AZ; Glerup H; Gronbaek H; Vedsted P
    Fam Pract; 2021 Sep; 38(5):589-597. PubMed ID: 33904928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients.
    Jensen H; Tørring ML; Olesen F; Overgaard J; Fenger-Grøn M; Vedsted P
    BMC Cancer; 2015 Apr; 15():308. PubMed ID: 25900050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement between patients and general practitioners on quality deviations during the cancer diagnostic pathway and associations with time to diagnosis.
    Jensen H; Sperling C; Sandager M; Vedsted P
    Fam Pract; 2015 Jun; 32(3):329-35. PubMed ID: 25888583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability.
    Ingeman ML; Christensen MB; Bro F; Knudsen ST; Vedsted P
    BMC Cancer; 2015 May; 15():421. PubMed ID: 25990247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of general practice in routes to diagnosis of lung cancer in Denmark: a population-based study of general practice involvement, diagnostic activity and diagnostic intervals.
    Guldbrandt LM; Fenger-Grøn M; Rasmussen TR; Jensen H; Vedsted P
    BMC Health Serv Res; 2015 Jan; 15():21. PubMed ID: 25608462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary care intervals before and after the introduction of urgent referral guidelines for suspected cancer in Denmark: a comparative before-after study.
    Larsen MB; Hansen RP; Hansen DG; Olesen F; Vedsted P
    BMC Health Serv Res; 2013 Sep; 13():348. PubMed ID: 24021054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
    Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
    BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Referrals from general practice to consultants in Germany: if the GP is the initiator, patients' experiences are more positive.
    Rosemann T; Wensing M; Rueter G; Szecsenyi J
    BMC Health Serv Res; 2006 Jan; 6():5. PubMed ID: 16423299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-specific symptoms and signs of cancer: different organisations of a cancer patient pathway in Denmark.
    Damhus CS; Siersma V; Dalton SO; Brodersen J
    Scand J Prim Health Care; 2021 Mar; 39(1):23-30. PubMed ID: 33629891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms.
    Pearson C; Poirier V; Fitzgerald K; Rubin G; Hamilton W
    BMJ Open; 2020 Jan; 10(1):e033008. PubMed ID: 31924638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.